Yifan Pharmaceutical Co., Ltd. (SHE:002019)
China
· Delayed Price · Currency is CNY 11.24
-0.02 (-0.18%)
Apr 29, 2026, 3:04 PM CST
Yifan Pharmaceutical Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Market Capitalization | 11,673 | 12,399 | 13,040 | 18,014 | 15,019 | 21,745 | Upgrade
|
| Market Cap Growth | -17.49% | -4.92% | -27.61% | 19.94% | -30.93% | -6.96% | Upgrade
|
| Enterprise Value | 13,162 | 13,917 | 14,371 | 19,400 | 16,499 | 22,717 | Upgrade
|
| Last Close Price | 11.26 | 11.96 | 10.63 | 14.52 | 12.03 | 17.31 | Upgrade
|
| PE Ratio | 38.57 | 30.84 | 33.78 | - | 78.54 | 78.11 | Upgrade
|
| Forward PE | - | 18.07 | 18.07 | 18.07 | 16.33 | 32.78 | Upgrade
|
| PS Ratio | 2.31 | 2.42 | 2.53 | 4.43 | 3.92 | 4.93 | Upgrade
|
| PB Ratio | 1.33 | 1.42 | 1.55 | 2.18 | 1.64 | 2.48 | Upgrade
|
| P/TBV Ratio | 2.59 | 2.80 | 3.29 | 4.67 | 2.82 | 4.23 | Upgrade
|
| P/FCF Ratio | - | - | 1037.05 | - | - | - | Upgrade
|
| P/OCF Ratio | 20.81 | 27.05 | 20.35 | 51.68 | 31.82 | 72.19 | Upgrade
|
| PEG Ratio | - | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | Upgrade
|
| EV/Sales Ratio | 2.60 | 2.71 | 2.79 | 4.77 | 4.30 | 5.15 | Upgrade
|
| EV/EBITDA Ratio | 17.36 | 18.03 | 20.26 | 70.93 | 43.52 | 50.06 | Upgrade
|
| EV/EBIT Ratio | 31.96 | 31.52 | 37.00 | 926.80 | 96.29 | 86.48 | Upgrade
|
| EV/FCF Ratio | -127.91 | - | 1142.95 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.27 | 0.27 | 0.27 | 0.24 | 0.24 | 0.26 | Upgrade
|
| Debt / EBITDA Ratio | 3.13 | 3.01 | 3.17 | 6.84 | 5.44 | 4.84 | Upgrade
|
| Debt / FCF Ratio | - | - | 182.47 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.19 | 0.19 | 0.17 | 0.15 | 0.10 | 0.11 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.18 | 2.11 | 1.98 | 4.47 | 2.47 | 2.07 | Upgrade
|
| Net Debt / FCF Ratio | -15.78 | -16.16 | 111.73 | -7.86 | -13.35 | -3.47 | Upgrade
|
| Asset Turnover | 0.40 | 0.41 | 0.43 | 0.34 | 0.31 | 0.37 | Upgrade
|
| Inventory Turnover | 2.40 | 2.38 | 2.77 | 2.43 | 2.65 | 4.16 | Upgrade
|
| Quick Ratio | 0.84 | 0.79 | 0.84 | 0.94 | 1.19 | 1.13 | Upgrade
|
| Current Ratio | 1.34 | 1.29 | 1.26 | 1.49 | 1.68 | 1.56 | Upgrade
|
| Return on Equity (ROE) | 3.82% | 4.36% | 3.88% | -10.18% | 1.42% | 2.77% | Upgrade
|
| Return on Assets (ROA) | 2.03% | 2.20% | 2.04% | 0.11% | 0.87% | 1.38% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.39% | 3.86% | 3.35% | 0.21% | 1.40% | 2.80% | Upgrade
|
| Return on Capital Employed (ROCE) | 4.10% | 4.50% | 4.20% | 0.20% | 1.70% | 2.70% | Upgrade
|
| Earnings Yield | 3.05% | 3.24% | 2.96% | -3.06% | 1.27% | 1.28% | Upgrade
|
| FCF Yield | -0.88% | -0.81% | 0.10% | -0.86% | -0.47% | -1.24% | Upgrade
|
| Dividend Yield | 0.89% | 0.84% | 1.88% | - | - | - | Upgrade
|
| Payout Ratio | 48.07% | 42.68% | 50.47% | - | 45.18% | 49.71% | Upgrade
|
| Buyback Yield / Dilution | -1.00% | -1.00% | 1.51% | 3.94% | -5.32% | 1.26% | Upgrade
|
| Total Shareholder Return | -0.11% | -0.17% | 3.39% | 3.94% | -5.32% | 1.26% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.